CommercialPrior AuthMedium impact
Corlanor (ivabradine)
Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Family Medicine, Internal Medicine·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their prior authorization policy for Corlanor (ivabradine), a heart failure medication. The policy requires prior auth and specifies detailed medical necessity criteria including heart rate thresholds, contraindications to beta blockers, and requires prescriber to be or consult with a board-certified cardiologist.
Action Required
Immediately: Billing team must ensure prior authorization is obtained before prescribing Corlanor (ivabradine) for BCBS Mississippi patients. Providers must verify patient meets all criteria: heart failure with ejection fraction ≤35%, heart rate ≥70 bpm, maximally tolerated beta blockers or contraindication, and prescriber is/consulted with board-certified cardiologist. Perform formulary drug search on patient's member ID before prescribing. Claims will be denied without prior authorization.